Development of Self-Detoxifying Filter Media for Active Decontamination

开发用于主动净化的自解毒过滤介质

基本信息

  • 批准号:
    10155952
  • 负责人:
  • 金额:
    $ 25.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-11 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Systems that utilize various filtration media are one of the first lines of defense against aerosolized pathogens. They are critical in providing a safe/clean environment for patients, medical personnel, or researchers. Without these filters, those with compromised immune systems, or those working with highly contagious pathogens, can face deadly situations. Even with these filters in place, certain pathogens have the potential to pass through or even survive within the filter. Due to the small size of many viruses, the coronavirus SARS-CoV-2 is ~100nm, no filter is 100% effective at capturing all aerosolized pathogens. Furthermore, re- aerosolization of certain captured pathogens can also take place during normal use, when the filter is assessed to determine its remaining lifespan, or when the filter needs to be replaced entirely. Herein lies Lynntech’s focus in this area. Lynntech plans to address these shortcomings in filtration media through the addition of novel solid and stable hydroperoxy ligands that will immediately, and continually, terminate captured aerosolized pathogens such as the coronavirus SARS-CoV-2 virus that causes COVID-19. Self-detoxifying filters would allow for the complete termination of any pathogen that might normally remain active on untreated filters as well as eliminate the potential for re-aerosolization of active pathogens. This would allow for not only increased protection of those relying on the filters, but also mitigate the risks of those who would normally assess or change the filters. Many of the efforts towards the modification of filtration media for active decontamination have been partially successful, however, they have all come with their own drawbacks that Lynntech will attempt overcome with its own method of filter modification. During this Phase 1 project, Lynntech will demonstrate proof-of-concept by pursuing the following specific aims: (1) functionalization of commercial fiberglass-based filter media with hydroperoxy ligands, (2) assessment of antimicrobial properties of hydroperoxy-treated filters, and (3) evaluation of the “irreversibility” and safety of bound hydroperoxy ligands. Successful completion of these specific aims should demonstrate ample feasibility of using Lynntech’s filter modification technology and allow for Lynntech to plan more comprehensive technology development and commercialization avenues. Overall, this technology provides a great opportunity to drastically improve the safety of those who are working or healing in potentially harmful environments. This technology could even be extended to further decontamination avenues such as chemical warfare agents, or toxic industrial chemicals.
项目摘要 利用各种过滤介质的系统是防止雾化的第一道防线之一。 病原体它们对于为患者、医务人员或其他人员提供安全/清洁的环境至关重要。 研究人员如果没有这些过滤器,那些免疫系统受损的人,或者那些工作在高水平的人, 传染性病原体,可能面临致命的情况。即使有了这些过滤器,某些病原体仍然具有 有可能通过过滤器,甚至在过滤器中存活。由于许多病毒的体积很小, SARS-CoV-2是~ 100 nm,没有过滤器是100%有效地捕捉所有雾化的病原体。此外,再-- 当对过滤器进行评估时,某些捕获的病原体的气溶胶化也可以在正常使用期间发生 以确定其剩余寿命,或何时需要完全更换过滤器。这就是Lynntech的重点 在这一地区。Lynntech计划通过添加新型固体颗粒来解决过滤介质中的这些缺点。 和稳定的过氧氢配体,其将立即并持续地终止捕获的气溶胶化病原体 例如导致COVID-19的冠状病毒SARS-CoV-2。自我解毒过滤器将允许 完全终止任何可能在未处理的过滤器上正常保持活性的病原体, 活性病原体重新雾化的可能性。这不仅可以增加对这些人的保护, 这不仅减少了对过滤器的依赖,而且还减轻了那些通常会评估或更换过滤器的人的风险。许多 为主动净化而改进过滤介质的努力已经部分地 然而,成功的,他们都有自己的缺点,Lynntech将试图克服其 自己的过滤器修改方法。在第一阶段项目中,Lynntech将通过以下方式展示概念验证: 追求以下具体目标:(1)商业玻璃纤维基过滤介质的功能化, 过氧化氢配体,(2)过氧化氢处理过的过滤器的抗微生物性能评估,和(3)评价 的“不可逆性”和安全性的结合过氧氢配体。圆满完成这些具体目标 应证明使用Lynntech的过滤器修改技术的充分可行性,并允许Lynntech 规划更全面的技术开发和商业化途径。总的来说,这项技术 提供了一个很好的机会,大大提高那些谁是工作或愈合的潜在安全 有害环境。这项技术甚至可以扩展到进一步的净化途径,如 化学战剂或有毒工业化学品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID Mark BATTAGLIA其他文献

DAVID Mark BATTAGLIA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID Mark BATTAGLIA', 18)}}的其他基金

Enhanced Non fouling Membranes for Water Purification and Recycling
用于水净化和回收的增强型防污膜
  • 批准号:
    8779813
  • 财政年份:
    2014
  • 资助金额:
    $ 25.08万
  • 项目类别:
Enhanced Non Fouling Membranes for Water Purification and Recycling
用于水净化和回收的增强型防污膜
  • 批准号:
    9355646
  • 财政年份:
    2014
  • 资助金额:
    $ 25.08万
  • 项目类别:
High Yield and Inexpensive Production of Quality Gold Nanocrystals for Bio-Labels
高产且廉价地生产用于生物标签的优质金纳米晶体
  • 批准号:
    7052658
  • 财政年份:
    2006
  • 资助金额:
    $ 25.08万
  • 项目类别:
Kits for Converting Nanocrystals to Standard Bio-Medical Reagents
将纳米晶体转化为标准生物医学试剂的试剂盒
  • 批准号:
    7498032
  • 财政年份:
    2003
  • 资助金额:
    $ 25.08万
  • 项目类别:
MATERNAL AGING AND MEIOTIC REGULATION IN OOCYTES
母体衰老和卵母细胞减数分裂调节
  • 批准号:
    2673768
  • 财政年份:
    1994
  • 资助金额:
    $ 25.08万
  • 项目类别:
MATERNAL AGING AND MEIOTIC REGULATION IN OOCYTES
母体衰老和卵母细胞减数分裂调节
  • 批准号:
    2204738
  • 财政年份:
    1994
  • 资助金额:
    $ 25.08万
  • 项目类别:
MATERNAL AGING AND MEIOTIC REGULATION IN OOCYTES
母体衰老和卵母细胞减数分裂调节
  • 批准号:
    2204737
  • 财政年份:
    1994
  • 资助金额:
    $ 25.08万
  • 项目类别:
MATERNAL AGING AND MEIOTIC REGULATION IN OOCYTES
母体衰老和卵母细胞减数分裂调节
  • 批准号:
    2204736
  • 财政年份:
    1994
  • 资助金额:
    $ 25.08万
  • 项目类别:
MATERNAL AGING AND MEIOTIC REPRODUCTION IN OOCYTES
母体衰老和卵母细胞减数分裂繁殖
  • 批准号:
    2889117
  • 财政年份:
    1994
  • 资助金额:
    $ 25.08万
  • 项目类别:
MATERNAL AGING AND MEIOTIC REPRODUCTION IN OOCYTES
母体衰老和卵母细胞减数分裂繁殖
  • 批准号:
    2389521
  • 财政年份:
    1994
  • 资助金额:
    $ 25.08万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了